Lycopene
Clinical Studies
Effects of menopause and hormone replacement therapy on serum levels of coenzyme Q10 and other lipid-soluble antioxidants.
Association of carotenoids, tocopherols and vitamin C in plasma with allergic rhinitis and allergic sensitisation in adults.
Split prostate cancer four ways, Willett says.
Extraction of lycopene from tomato skin with supercritical carbon dioxide: effect of operating conditions and solubility analysis.
Differences in the carotenoid content of ordinary citrus and lycopene-accumulating mutants.
Bioaccessibility of beta-carotene, lutein, and lycopene from fruits and vegetables.
Prospective study of fruits and vegetables and risk of oral premalignant lesions in men.
Cardiovascular disease mortality and serum carotenoid levels: a Japanese population-based follow-up study.
Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyll, and selected oxidative metabolites with 5-lipoxygenase.
Chemopreventive potential of diallylsulfide, lycopene and theaflavin during chemically induced colon carcinogenesis in rat colon through modulation of cyclooxygenase-2 and inducible nitric oxide synthase pathways.
Intake of the major carotenoids and the risk of epithelial ovarian cancer in a pooled analysis of 10 cohort studies.
Effects of thymoquinone, lycopene, and selenomethione in the presence of estrogen on the viability of SiHa cells in vitro.
A chromoplast-specific carotenoid biosynthesis pathway is revealed by cloning of the tomato white-flower locus.
Risk assessment for the carotenoids lutein and lycopene.
Tissue differential expression of lycopene beta-cyclase gene in papaya.
Plasma lycopene, other carotenoids, and the risk of type 2 diabetes in women.
Metabolic engineering of potato tuber carotenoids through tuber-specific silencing of lycopene epsilon cyclase.
Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective.
Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes.
Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy.
Page 2 of 25
